SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013037
Filing Date
2018-05-10
Accepted
2018-05-10 17:03:12
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q insy-10q_20180331.htm 10-Q 2202247
2 EX-10.3 insy-ex103_165.htm EX-10.3 33712
3 EX-31.1 insy-ex311_14.htm EX-31.1 9123
4 EX-31.2 insy-ex312_13.htm EX-31.2 9004
5 EX-32 insy-ex32_12.htm EX-32 9109
  Complete submission text file 0001564590-18-013037.txt   9320028

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT insy-20180331.xml EX-101.INS 2596906
7 XBRL TAXONOMY EXTENSION SCHEMA insy-20180331.xsd EX-101.SCH 45310
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20180331_cal.xml EX-101.CAL 52606
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20180331_def.xml EX-101.DEF 159330
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20180331_lab.xml EX-101.LAB 364592
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20180331_pre.xml EX-101.PRE 301654
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 18823858
SIC: 2834 Pharmaceutical Preparations